Optiver Holding
TNYA icon

Optiver Holding’s Tenaya Therapeutics TNYA Stock Holding History

Optiver Holding’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99 Buy
134
+40
+43% +$30 ﹤0.01% 2644
2026
Q1 		$65 Buy
94
+40
+74% +$30 ﹤0.01% 2254
2025
Q4 		$38 Hold
54
– – ﹤0.01% 2401
2025
Q3 		$87 Buy
+54
New +$54 ﹤0.01% 2601

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Optiver Holding's TNYA Position: Q2 2026 in Review

Optiver Holding increased its Tenaya Therapeutics (TNYA) stake by 43% in Q2 2026, buying an estimated $30 and bringing the position to 134 shares worth $99. The position accounts for ﹤0.01% of the portfolio, ranked #2644.

Optiver Holding first reported a position in TNYA in Q3 2025 and has held it in 4 quarters since. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Optiver Holding held 134 shares of Tenaya Therapeutics worth $99 as of Q2 2026.
  • Optiver Holding bought 40 Tenaya Therapeutics shares in Q2 2026, an estimated $30.
  • Tenaya Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2644 holding.
  • Optiver Holding first reported a position in Tenaya Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.